For over a decade, the enhancement of regulated exocytosis by cAMP-dependent protein kinase (PKA) has remained unexplained at the molecular level. The fact that this phenomenon has been observed in such a wide variety of secretory cell types, from pancreatic β-cells to neurons, suggests that it is an important and fundamental mechanism. Extensive analysis of the phosphorylation of exocytotic proteins has yielded few substrates of PKA in vitro, and fewer still have had physiological effects attributed to their phosphorylation. Here we review two proteins that do fulfil these criteria: the synaptic vesicle proteins cysteine string protein (CSP) and Snapin. Phosphorylation of these proteins by PKA produces changes in their respective proteinprotein interactions, and has been attributed to modulation of the vesicle priming (Snapin) and vesicle fusion (CSP) stages of exocytosis. We also discuss how the function of CSP and Snapin phosphorylation might fit into an interesting aspect of the PKA-dependent enhancement of exocytosis: presynaptic plasticity in the brain.
Introduction
The process of vesicle fusion at the plasma membrane has been shown to involve a minimum complex of three proteins: the SNARE [soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor] proteins (reviewed in [1] ), comprising one vesicular-or v-SNARE [e.g. VAMP2 (vesicle-associated membrane protein 2) in neurons] and two target or t-SNAREs [e.g. syntaxin and SNAP-25 (synaptosomal-associated protein of 25 kDa) in neurons] [2] . In vitro, these proteins have been shown to be sufficient for full membrane fusion, albeit at a lower rate than that observed in vivo (t 1/2 = 10 min, compared with a few hundred µs in synapses [3] ). Thus many factors have been characterized that regulate the formation of SNARE complexes and subsequent fusion to produce fast, finely tuned exocytosis. For example, a defining feature of regulated exocytosis is its calcium dependency, which is thought to be mediated by the vesicle membrane protein synaptotagmin [4] .
A further level of regulation can be applied through post-translational modification of the exocytotic machinery, most notably by phosphorylation [5] . Early experiments involving the application of kinase activators and inhibitors to intact secretory cells suggested that kinase activity enhances secretion. However, the locus of these effects could not be attributed solely to the exocytotic machinery, since kinase modulators are also known to modulate or sterically interfere with ion channels and receptors that are activated by secretagogues (e.g. [6] ). A more thorough approach involves the application of kinases or their agonists to permeabilized cells while secretion is elicited by a low micromolar concentration of Ca 2+ , thus bypassing the effects of channels and receptors. Under these conditions, exocytosis is consistently modulated by cAMP-dependent protein kinase (PKA) and its activators [7] [8] [9] . Furthermore, PKA has been shown to enhance exocytosis by acting at different stages of the vesicle cycle, e.g. on the rate of vesicle cycling and the number of release sites [10] , at an early Ca 2+ -sensing step [11] , and at a late step on the kinetics of individual release events [12] . Despite this, PKA substrates involved in exocytosis have not been forthcoming, a surprising state of affairs considering the universality of the PKA-dependent enhancement of exocytosis. In this paper we review the few PKA substrates that have been implicated in the regulation of exocytosis, and attempt to apply the current molecular understanding of this phenomenon to the growing amount of physiological data on PKA-dependent presynaptic plasticity in the brain.
Candidates for the regulation of exocytosis by PKA Table 1 summarizes the substrates of PKA that have been proposed as candidates for the regulation of exocytosis by PKA. Of these, αSNAP and syntaxin 4 are phosphorylated in vitro by PKA and display altered protein-protein interactions [13, 14] ; however, αSNAP phosphorylation has not been detected in vivo [15] , and phosphorylation of syntaxin 4 in platelets has been attributed to protein kinase [14, 16] C [16] . The PKA-mediated phosphorylation of SNAP-25, and in particular of rabphilin 3A, has been characterized extensively both in vitro and in vivo [13, [17] [18] [19] [20] [21] [22] ; however, phosphorylation-dependent effects upon exocytosis have yet to be found. Thus, to date, only two exocytotic proteins have been shown to be phosphorylated by PKA both in vitro and in vivo and have demonstrable effects of their phosphorylated residues upon exocytosis; these are cysteine string protein (CSP) and Snapin [15, 23] .
CSP is a ubiquitous secretory vesicle membrane protein which is localized exclusively to vesicle membranes by its palmitoylated 'cysteine string', a motif of 14 cysteine residues within a 20-amino-acid stretch. CSP is a member of the DnaJ family of co-chaperones, and biochemical experiments have demonstrated a co-chaperone activity of CSP in a complex with the chaperone Hsc70 and SGT (small glutamine-rich), a tetratricopeptide repeat protein, to drive the correct folding of polypeptides [24] [25] [26] . Genetic experiments in Drosophila have shown that CSP is essential for a Ca 2+ -dependent step of synaptic vesicle exocytosis, downstream of Ca 2+ entry [27, 28] . Taken together, these studies suggest a role for CSP in mediating correct protein folding or assembly of protein complexes in a late stage of exocytosis (reviewed in [29] ). In support of this, CSP has been shown to bind both syntaxin and the putative Ca 2+ sensor, synaptotagmin [15, 30, 31] , the latter being potentially relevant to the Ca 2+ -dependent phenotype of CSP mutant Drosophila.
Snapin was identified as a SNAP-25 binding protein in a yeast two-hybrid screen. It is localized exclusively to synaptic vesicle membranes, and is expressed predominantly in the brain [32] . The interaction of SNAP-25 with Snapin occurs with a 1:1 stoichiometry, involves the C-terminal half of Snapin, and can occur simultaneously with that of the SNARE complex. The C-terminus of Snapin inhibits binding of synaptotagmin to the SNARE complex and inhibits neurotransmission upon injection into cultured neurons. Interestingly, addition of full-length Snapin to rat brain homogenates leads to increased recovery of synaptotagmin bound to SNARE complexes; however, in that study, fulllength Snapin was not injected into neurons to determine its effect upon neurotransmission [32] .
The data on the phosphorylation of CSP on Ser 10 and of Snapin on Ser 50 by PKA are very similar. Both are phosphorylated by PKA in vitro and in model in vivo systems by incubation with non-hydrolysable cAMP analogues [15, 23] . The phosphorylation of CSP inhibits its interactions with syntaxin and synaptotagmin in vitro and in pull-down assays, while Snapin phosphorylation enhances its interaction with SNAP-25 and increases the interaction of synaptotagmin with the SNARE complex in vitro and in hippocampal slices [15, 23, 30] . These phosphorylation-dependent alterations in protein-protein interactions with key exocytotic proteins make CSP and Snapin excellent candidates for involvement in the regulation of the exocytotic machinery by PKA. However, demonstrating the functional significance of such phosphorylation events for physiological processes has proved exceptionally difficult. An increasingly common approach is the use of phosphomimetic mutations, whereby the phosphorylated residue of a protein is replaced with a glutamate or aspartate residue, with the rationale that the negatively charged side chain of an acidic amino acid mimics the addition of a phosphate moiety. Conversely, substitution with an alanine residue produces a nonphosphorylatable protein. Physiological analysis of the phosphorylation of both CSP and Snapin was carried out using the same experimental system: transfection of bovine adrenal chromaffin cells with phosphorylation-site mutant proteins, followed by electrophysiological recordings.
Overexpression of wild-type (and consequently phosphorylatable) CSP in chromaffin cells produces two distinct effects, as measured by amperometry of catecholamine secretion: (i) a large inhibition of exocytosis and (ii) a slowing of release kinetics in the remaining fusion events [33] . When a non-phosphorylatable mutant of CSP (S10A) was overexpressed, inhibition of exocytosis was again observed (clearly a phosphorylation-independent effect of CSP, perhaps mediated by a titration of CSP binding partners); however, the slowing effect upon release kinetics was absent [15] . In support of this phenomenon being associated with the phosphorylation of CSP by PKA, treatment of chromaffin cells with forskolin or other agents that increase cellular cAMP levels produces the same slowing effect upon release kinetics, with a concomitant increase in quantal size (M.E. Graham and R.D. Burgoyne, personal communication; [12] ). If CSP has a role in chaperoning the interactions of syntaxin and synaptotagmin during exocytosis, then an inability of phosphorylated CSP to bind and recruit a chaperone complex to these proteins could allow them to bind other proteins that are involved in slowing the kinetics of release events. The syntaxin-binding protein nSec1 is such a candidate, since it has been shown that when nSec1-syntaxin binding is inhibited, the kinetics of release are accelerated [34] , implying a slowing effect of the protein's interaction with syntaxin. An indication that the freeing of synaptotagmin from CSP is involved in the slowing of release kinetics comes from a study in which overexpression of synaptotagmin (which we predict would produce a high concentration of free synaptotagmin) in PC12 cells prolonged the kinetics of fusion pore opening [35] . A further possibility is that CSP, once phosphorylated, binds to an unknown protein that is involved in altering release kinetics. Further experiments are required to test these hypotheses.
Overexpression of a phosphomimetic (S50D) or unphosphorylatable (S50A) Snapin mutant produced an enhancement of the sustained component of exocytosis (interpreted as a phosphorylation-independent effect of Snapin overexpression upon the increased priming of vesicles prior to fusion). However, the S50D mutant enhanced the initial exocytotic burst whereas the S50A mutant reduced it, suggesting that the phosphorylation of Snapin leads to increased stabilization of release-ready vesicles [23] . These data are consistent with the increased binding of phosphorylated Snapin to SNAP-25 and of synaptotagmin to the SNARE complex observed in vitro that would account for increased stability of assembled complexes during priming. Thus PKA could regulate the exocytotic machinery at two different stages of the vesicle cycle: at an early stage during priming, via phosphorylation of Snapin; and at a late stage during membrane fusion, via phosphorylation of CSP.
Presynaptic plasticity: a physiological correlate of PKA-mediated regulation of the exocytotic machinery?
Remodelling of the strength (i.e. the amplitude of the postsynaptic response generated by the activity of the presynaptic cell) of synapses in the brain is the current model for the molecular basis of learning and memory. There has been considerable debate concerning the locus of such plasticity, i.e. whether pre-or post-synaptic, although the accumulating evidence in different systems for modifications on each side of the synapse suggest both have physiological importance. The data on the regulation of exocytotic proteins by PKA described above provide an attractive molecular explanation for how neurotransmitter release is enhanced to produce a persistent but reversible modification of presynaptic activity. Are there any data to support this theory? Various model systems have been studied that have a presynaptic contribution to plasticity and, indeed, the majority of these have been demonstrated to be dependent upon PKA activity, e.g. long-term potentiation (LTP) in hippocampal mossy fibre-CA3 synapses [36] , cerebellar granule cell-Purkinje cell synapses [37] [38] [39] , corticostriatal synapses [40] and corticothalamic synapses [41] , and presynaptic facilitation in cultured hippocampal neurons [42] , cerebellar granule cell cultures [10] , the Calyx of Held [43] and the squid giant synapse [44] . Evidence for direct modification of the exocytotic machinery by PKA has been demonstrated by Trudeau et al. [42] , who stimulated exocytosis with Ruthenium Red, thus bypassing Ca 2+ channels and receptors, and still found an enhancement of neurotransmitter release in response to PKA activation. In a later study, these authors presented data to suggest that PKA acts upon a Ca 2+ -sensing step of exocytosis [11] ; intriguingly, this is consistent with the phosphorylation-dependent regulation of synaptotagmin function by Snapin or CSP, and with the phenotype of CSPnull mutant Drosophila we have already discussed [23, 27, 30] .
A recent body of work has led to the identification of key proteins involved in PKA-dependent hippocampal mossy fibre LTP (mfLTP) (reviewed in [45] ). An initial observation was made that mice lacking Rab3A, a synaptic vesicle protein implicated in vesicle trafficking, do not exhibit hippocampal mfLTP [46] . Rab3A is not a PKA substrate, and thus downstream Rab3A effectors were studied for their effects upon mfLTP. Mice lacking rabphilin 3A, a Rab3A effector and PKA substrate, had normal mfLTP [47] ; however, mice deficient in RIM (Rab3A-interacting molecule) 1, a presynaptic scaffolding protein and Rab3A effector [48] , did not exhibit mfLTP [49] . Similar results were found for granule cell-Purkinje cell LTP in the cerebellum of RIM1 knockout mice, suggesting a universal mechanism for presynaptic plasticity in the brain [49] . Furthermore, RIM1 has a PKA phosphorylation consensus sequence, and there are unpublished observations that it is an in vivo substrate for PKA and binds a regulatory subunit of PKA (mentioned in [45, 49] ). The role of RIM1 in exocytosis is not fully understood, but the RIM1-null mutation in Caenorhabditis elegans reduces the number of fusion-competent vesicles, suggesting a function in priming. Interestingly, this mutation can be suppressed with a mutation in syntaxin that maintains it in an 'open conformation', the form of syntaxin involved in SNARE complex formation [50] . Thus the induction of mfLTP to enhance neurotransmitter release might involve a signalling cascade from Rab3A via RIM1 that increases the proportion of syntaxin available for SNARE complex formation, with one or more steps dependent upon PKA. The altered proteinprotein interactions involved in SNARE complex formation that we have described for the function of CSP and Snapin phosphorylation are compatible with this hypothesis.
Conclusions
Progress has been made in identifying substrates that underlie the molecular mechanism behind the PKA-dependent enhancement of exocytosis. CSP and Snapin are the most promising proteins, based on functional studies of exocytosis using phosphomimetic mutants; however, the functions of rabphilin 3A and SNAP-25 phosphorylation by PKA are yet to be determined. Its ubiquitous expression throughout the body makes CSP a prime candidate for the PKAdependent regulation of non-neuronal secretion, since Snapin is predominantly neuronal. In the brain, this regulation is particularly pertinent, since the fine tuning of synaptic connections is a fundamental aspect of brain function. A previous inability to access the presynaptic nerve terminal either biochemically or electrophysiologically has made it difficult to research the regulation of neuronal exocytosis at the molecular level. However, tools such as knock-out or 'knock-in' mice, transfection or infection of primary neuronal cultures or brain slices and the generation of phosphospecific antibodies should make it possible to test the involvement of CSP and Snapin in PKA-dependent presynaptic plasticity. The Rab3A/RIM1 pathway has already been identified as a key player in presynaptic LTP, and we now wait to see how it integrates with PKA signalling and also whether it feeds into the mechanisms of CSP and/or Snapin phosphorylation.
